Markets:

Overview

News

Currencies

International

Treasuries

Illumina, Inc. - Common Stock (NQ:ILMN)

215.59 -12.10 (-5.31%)

Streaming Delayed Price Updated: 4:00 PM EDT, Aug 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

39 40 Next >

Global AI Diagnostics Market to Reach $8.54 Billion By 2033 as Industry Sees Increasing R&D and Strategic Collaborations

April 16, 2025

EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:ILMN),(NASDAQ:TEM),(NYSE:MDT),(NASDAQ:MDAI) EQNX::TICKER_END

Via FinancialNewsMedia

Topics Artificial Intelligence

1 Healthcare Stock for Long-Term Investors and 2 to Keep Off Your Radar

April 11, 2025

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID...

Via StockStory

Topics Stocks

Demystifying Illumina: Insights From 11 Analyst Reviews ↗

March 05, 2025

Via Benzinga

Here's How Much $1000 Invested In Illumina 20 Years Ago Would Be Worth Today ↗

March 03, 2025

Via Benzinga

$1000 Invested In Illumina 20 Years Ago Would Be Worth This Much Today ↗

February 25, 2025

Via Benzinga

Earnings Scheduled For May 8, 2025 ↗

May 08, 2025

Via Benzinga

Earnings To Watch: Illumina (ILMN) Reports Q1 Results Tomorrow

May 06, 2025

Genomics company Illumina (NASDAQ:ILMN) will be announcing earnings results this Thursday afternoon. Here’s what to expect.

Via StockStory

Assessing Illumina: Insights From 16 Financial Analysts ↗

April 29, 2025

Via Benzinga

Rep. Thomas Kean Has Bought Up to $45K Worth Of Illumina Stock: Here's What You Should Know ↗

April 21, 2025

Via Benzinga

Q4 Rundown: Illumina (NASDAQ:ILMN) Vs Other Life Sciences Tools & Services Stocks

April 18, 2025

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Illumina (NASDAQ:ILMN) and the...

Via StockStory

Topics Artificial Intelligence

Global AI Diagnostics Market to Reach $8.54 Billion By 2033 as Industry Sees Increasing R&D and Strategic Collaborations

April 16, 2025

From FN Media Group LLC

Via GlobeNewswire

Got $3,000? 2 Artificial Intelligence (AI) Stocks to Buy and Hold for the Long Term ↗

April 09, 2025

Via The Motley Fool

Topics Artificial Intelligence

Deep Dive Into Illumina Stock: Analyst Perspectives (14 Ratings) ↗

April 07, 2025

Via Benzinga

Apple To $250? Here Are 10 Top Analyst Forecasts For Monday ↗

April 07, 2025

Via Benzinga

How Do Investors Really Feel About Illumina? ↗

April 07, 2025

Via Benzinga

Here's How Much $1000 Invested In Illumina 20 Years Ago Would Be Worth Today ↗

April 01, 2025

Via Benzinga

3 Mid-Cap Stocks Walking a Fine Line

April 01, 2025

Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with...

Via StockStory

The Future of Healthcare: 10 Predictions For The Next Decade

March 27, 2025

The healthcare industry stands on the brink of a transformative decade, driven by rapid advancements in technology, shifting demographics, and evolving patient expectations. Over the next ten years, we...

Via MarketMinute

Topics Artificial Intelligence

The Future of the Military: 10 Predictions for the Next Decade

March 27, 2025

The military landscape has always been a dynamic arena, shaped by technological advancements, geopolitical shifts, and evolving threats. As we stand in 2025, the world is on the cusp of transformative...

Via MarketMinute

Topics Artificial Intelligence Climate Change Energy

How Tariffs Are Rocking The 'Bubblegum And Shoestring' Medical Supply Chain ↗

March 27, 2025

Uncertainty has cast a pall over medical stocks, which are taking a "wait-and-see" approach to Trump's tariffs.

Via Investor's Business Daily

Topics Government

Cathie Wood's Ark Invest Scoops Up Iridium, Beam, Pacific Biosciences While Offloading Illumina And Amgen ↗

March 22, 2025

Cathie Wood-led Ark Invest made notable trades, buying IRDM, BEAM, PACB, ABSI and selling ILMN, RPTX, AMGN, VEEV.

Via Benzinga

Jim Cramer Says Illumina Is 'Challenged,' Recommends Selling This Industrial Stock ↗

March 14, 2025

Cramer looks at Illumina, Archer Aviation, NANO Nuclear Energy, Steris, Sixth Street Specialty Lending, Lam Research and Arista Networks.

Via Benzinga

Nvidia Stock Reached All-Time Highs After Jensen Huang's CES Keynote — Will Next Week's GTC Spark Another Surge? ↗

March 13, 2025

Jensen Huang will give a keynote speech at Nvidia's GTC conference next week. A keynote from Huang at CES earlier this year took Nvidia stock to highs.

Via Benzinga

Tesla To $120? Here Are 10 Top Analyst Forecasts For Wednesday ↗

March 12, 2025

Via Benzinga

Goldman Sachs Gains Confidence In Market Rebound, Upgrades GE Healthcare Amid China Recovery Hopes ↗

March 11, 2025

Goldman Sachs upgrades GE Healthcare to Buy, raising its price target to $100, as analysts see market stabilization and China sales recovering faster than expected.

Via Benzinga

Diagnostic Kit Maker Illumina To Cut $100 Million In Costs, Lowers 2025 Profit Outlook Amid China Trade Restrictions ↗

March 11, 2025

Illumina slashes costs by $100 million after China bans its sequencers. The company lowers its 2025 EPS outlook and aims for high-single-digit growth by 2027.

Via Benzinga

3 Reasons to Sell ILMN and 1 Stock to Buy Instead

March 07, 2025

What a brutal six months it’s been for Illumina. The stock has dropped 30.9% and now trades at $84.65, rattling many shareholders. This may have investors wondering how to approach the situation.

Via StockStory

Illumina Stock Slammed As China Retaliates Against Trump's Tariffs ↗

March 04, 2025

The company's gene-mapping products are now banned from import in China amid the escalating trade war between the U.S. and China.

Via Investor's Business Daily

Topics Government World Trade

US Firm Illumina Faces Setback as China Blocks Imports Amid Escalating Trade War ↗

March 04, 2025

China banned imports of Illumina's gene sequencers as new U.S. tariffs took effect, cutting its market access while Chinese rivals gain ground in the biotech sector.

Via Benzinga

Topics World Trade

GenoFAB Launches Hybrid Plasmid Sequencing Service To Set a New Standard for Reproducibility in Biotechnology

February 24, 2025

Via Get News

< Previous 1 2 3 4 5 6 7 8 9

...

39 40 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.